Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience

Guardado en:
Detalles Bibliográficos
Autores principales: Daniele Cattaneo, Cristina Bucelli, Francesca Cavallaro, Dario Consonni, Alessandra Iurlo
Formato: article
Lenguaje:EN
Publicado: Nature Publishing Group 2021
Materias:
Acceso en línea:https://doaj.org/article/983e9ce4878e41a585c00114ff2103c3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:983e9ce4878e41a585c00114ff2103c3
record_format dspace
spelling oai:doaj.org-article:983e9ce4878e41a585c00114ff2103c32021-11-28T12:41:09ZImpact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience10.1038/s41408-021-00579-02044-5385https://doaj.org/article/983e9ce4878e41a585c00114ff2103c32021-11-01T00:00:00Zhttps://doi.org/10.1038/s41408-021-00579-0https://doaj.org/toc/2044-5385Daniele CattaneoCristina BucelliFrancesca CavallaroDario ConsonniAlessandra IurloNature Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBlood Cancer Journal, Vol 11, Iss 11, Pp 1-3 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Daniele Cattaneo
Cristina Bucelli
Francesca Cavallaro
Dario Consonni
Alessandra Iurlo
Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience
format article
author Daniele Cattaneo
Cristina Bucelli
Francesca Cavallaro
Dario Consonni
Alessandra Iurlo
author_facet Daniele Cattaneo
Cristina Bucelli
Francesca Cavallaro
Dario Consonni
Alessandra Iurlo
author_sort Daniele Cattaneo
title Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience
title_short Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience
title_full Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience
title_fullStr Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience
title_full_unstemmed Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience
title_sort impact of diagnosis and treatment on response to covid-19 vaccine in patients with bcr-abl1-negative myeloproliferative neoplasms. a single-center experience
publisher Nature Publishing Group
publishDate 2021
url https://doaj.org/article/983e9ce4878e41a585c00114ff2103c3
work_keys_str_mv AT danielecattaneo impactofdiagnosisandtreatmentonresponsetocovid19vaccineinpatientswithbcrabl1negativemyeloproliferativeneoplasmsasinglecenterexperience
AT cristinabucelli impactofdiagnosisandtreatmentonresponsetocovid19vaccineinpatientswithbcrabl1negativemyeloproliferativeneoplasmsasinglecenterexperience
AT francescacavallaro impactofdiagnosisandtreatmentonresponsetocovid19vaccineinpatientswithbcrabl1negativemyeloproliferativeneoplasmsasinglecenterexperience
AT darioconsonni impactofdiagnosisandtreatmentonresponsetocovid19vaccineinpatientswithbcrabl1negativemyeloproliferativeneoplasmsasinglecenterexperience
AT alessandraiurlo impactofdiagnosisandtreatmentonresponsetocovid19vaccineinpatientswithbcrabl1negativemyeloproliferativeneoplasmsasinglecenterexperience
_version_ 1718407847605174272